Daiken Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 16, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	13,891	10,860	-	-
Enterprise Value	12,702	10,038	-	-
Last Close Price	231.50	174.20	-	-
PE Ratio	56.33	101.90	-	-
PS Ratio	8.53	7.97	-	-
PB Ratio	12.54	8.31	-	-
P/TBV Ratio	12.61	8.33	-	-
P/FCF Ratio	64.77	215.06	-	-
P/OCF Ratio	64.71	209.86	-	-
EV/Sales Ratio	7.80	7.37	-	-
EV/EBITDA Ratio	53.68	65.55	-	-
EV/EBIT Ratio	55.08	67.41	-	-
EV/FCF Ratio	59.23	198.77	-	-
Debt / Equity Ratio	0.00	0.00	1.12	0.60
Debt / EBITDA Ratio	0.00	0.01	1.35	1.21
Debt / FCF Ratio	0.00	0.05	2.63	3.27
Asset Turnover	0.93	1.19	1.87	-
Inventory Turnover	1.89	1.99	1.71	-
Quick Ratio	2.26	5.36	0.80	1.23
Current Ratio	2.87	6.56	1.64	2.17
Return on Equity (ROE)	20.95%	13.71%	67.55%	-
Return on Assets (ROA)	8.21%	8.15%	20.01%	-
Return on Capital (ROIC)	10.43%	10.15%	28.76%	-
Return on Capital Employed (ROCE)	20.80%	11.40%	68.80%	38.90%
Earnings Yield	1.78%	0.98%	-	-
FCF Yield	1.54%	0.46%	-	-
Dividend Yield	1.83%	2.31%	-	-
Payout Ratio	18.65%	2.89%	87.59%	-
Buyback Yield / Dilution	-139.65%	-95.20%	-44.34%	-
Total Shareholder Return	-137.82%	-92.88%	-44.34%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.